Maurizio Taglialatela

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Vincenzo Barrese

University of Naples Federico II

ITALY

View details

Alessandra BISIO

Assistant Professor

University of Trento

ITALY

View details

Elena Freri

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

View details

Christina Gurnett

Professor

Washington University in St. Louis

UNITED STATES

View details

Mattia Barbareschi

Professor of Pathology

University of Trento

ITALY

View details

Mauro Cataldi

Associate Professor in Pharmacology

University of Naples Federico II

ITALY

View details

Davide Mei

Dirigente Professioni Sanitarie Tecnico Diagnostiche

ITALY

View details

Jacopo C. DiFrancesco

University of Milano-Bicocca

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maurizio Taglialatela

Research Interests

Explore related searches

Contact this professor

Articles (15)

Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy

The epilepsy–autism phenotype associated with developmental and epileptic encephalopathies: New mechanism‐based therapeutic options

Targeting Kv7 Potassium Channels for Epilepsy

De novo variants in KCNA3 cause developmental and epileptic encephalopathy

A novel KCNC1 gain‐of‐function variant causing developmental and epileptic encephalopathy: “Precision medicine” approach with fluoxetine

Targeting shared molecular etiologies to accelerate drug development for rare diseases

Distinct epilepsy phenotypes and response to drugs in KCNA1 gain‐ and loss‐of function variants

Neurological risks and benefits of cytokine‐based treatments in coronavirus disease 2019: from preclinical to clinical evidence

The long and winding road to personalized medicine in KCNMA1‐linked channelopathies revealed by novel variants associated with the Liang‐Wang syndrome

Kv7.2 and Kv7.3 potassium channel subunits as new central regulators of blood pressure

Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors.

Neurobiology of coronaviruses: Potential relevance for COVID-19

The Role of Kv7.2 in Neurodevelopment: Insights and Gaps in Our Understanding.

A Novel Kv7.3 Variant in the Voltage-Sensing S<sub>4</sub> Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and <i>in vitro</i> Rescue by β-Hydroxybutyrate.

Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.

Collaborators (8)

Vincenzo Barrese

Alessandra BISIO

Elena Freri

Christina Gurnett

Mattia Barbareschi

Mauro Cataldi

Davide Mei

Jacopo C. DiFrancesco

Make your next move.